Rang	Name	Position
1	Mr. Gerard J. Michel MBA, MS	CEO & Director
2	Dr. Martha S. Rook Ph.D.	Chief Operating Officer
3	Dr. Vojislav Vukovic M.D., M.Sc., Ph.D.	Chief Medical Officer
4	Ms. Sandra Pennell C.P.A.	Chief Financial Officer
5	Mr. David Hoffman J.D.	General Counsel, Corporate Secretary & Chief Compliance Officer
6	Dr. Johnny John M.D.	Senior Vice President of Clinical Operations & Medical Affairs
7	Mr. Kevin Muir	Chief Commercial Officer
8	Dr. Michael Brunner M.D.	Senior Vice President of Interventional Oncology

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Rosalind Advisors, Inc.	9,51%	52,51 Mio. USD
2	BlackRock Inc	5,14%	28,39 Mio. USD
3	Vanguard Capital Management, LLC	3,83%	21,15 Mio. USD
4	Propel Bio Management LLC	2,51%	13,87 Mio. USD
5	Geode Capital Management, LLC	1,99%	11,01 Mio. USD
6	State Street Corp	1,91%	10,57 Mio. USD
7	Algert Global LLC	1,67%	9,24 Mio. USD
8	Millennium Management LLC	1,63%	9,01 Mio. USD
9	Divisadero Street Capital Management, LP	1,44%	7,95 Mio. USD
10	Ikarian Capital, LLC	1,24%	6,86 Mio. USD
11	Morgan Stanley - Brokerage Accounts	1,11%	6,13 Mio. USD
12	Private Wealth Advisors, LLC	0,90%	4,95 Mio. USD
13	The Goldman Sachs Group Inc	0,83%	4,60 Mio. USD
14	Simplify Asset Management Inc.	0,76%	4,21 Mio. USD
15	Northern Trust Corp	0,73%	4,01 Mio. USD
16	ADAR1 Capital Management LLC	0,65%	3,57 Mio. USD
17	Dimensional Fund Advisors, Inc.	0,61%	3,35 Mio. USD
18	Kennedy Capital Management Inc	0,59%	3,25 Mio. USD
19	Vanguard Fiduciary Trust Co	0,58%	3,21 Mio. USD
20	Royce & Associates, LP	0,56%	3,10 Mio. USD